N-(6-ethoxy-1,3-benzothiazol-2-yl)-3-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]benzamide
C22H17F3N4O4S — CID 139233098
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(6-ethoxy-1,3-benzothiazol-2-yl)-3-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]benzamide
N-(6-ethoxy-1,3-benzothiazol-2-yl)-3-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]benzamide (PubChem CID 139233098) has the molecular formula C22H17F3N4O4S and a molecular weight of 490.46 g/mol. Its IUPAC name is N-(6-ethoxy-1,3-benzothiazol-2-yl)-3-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]benzamide.
Molecular Properties
| Compound Name | N-(6-ethoxy-1,3-benzothiazol-2-yl)-3-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]benzamide |
|---|---|
| PubChem CID | 139233098 |
| Molecular Formula | C22H17F3N4O4S |
| Molecular Weight | 490.46 g/mol |
| Exact Mass | 490.09 |
| IUPAC Name | N-(6-ethoxy-1,3-benzothiazol-2-yl)-3-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]benzamide |
| SMILES | CCOc1ccc2nc(NC(=O)c3cccc(-n4c(=O)cc(C(F)(F)F)n(C)c4=O)c3)sc2c1 |
| InChI | InChI=1S/C22H17F3N4O4S/c1-3-33-14-7-8-15-16(10-14)34-20(26-15)27-19(31)12-5-4-6-13(9-12)29-18(30)11-17(22(23,24)25)28(2)21(29)32/h4-11H,3H2,1-2H3,(H,26,27,31) |
| InChIKey | OOZVBVRXSCNKDM-UHFFFAOYSA-N |
| XLogP | 3.82 |
| TPSA | 95.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 490.46 |
| LogP ≤ 5 | 3.82 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139233098 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.